AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions.
Pyruvate kinase (PK) deficiency may be underrecognized, but should be considered in patients with hemolysis who lack evidence of an acquired immune disorder. Visit the Agios exhibit to learn ...